Acquisitions
Acquisitions completed from the 2022 financial year are distributed among the group’s business areas as follows:
| Acquisitions | Time | Net Sales, SEKm* | Number of employees* | Business area |
|---|---|---|---|---|
| MBA Incorporado S.L, Spain | January, 2022 | 670 | 285 | Medtech |
| Business from Telia Health Monitoring, Sweden | March, 2022 | 4 | 8 | Medtech |
| O’Flynn Medical Ltd, Ireland | April, 2022 | 64 | 36 | Medtech |
| BioCat GmbH, Germany | April, 2022 | 90 | 20 | Labtech |
| JK Lab Nordic AB, Sweden | July, 2022 | 24 | 6 | Labtech |
| 852 | 355 | |||
| * Refers to conditions at the time of acquisition on a full-year basis. | ||||
Revaluation of liabilities for contingent considerations regarding previous acquisitions has resulted in income of SEK 83m of which 82m relates to the acquisition of AddVision. During the interim period, this has been reversed and reported in other operating income. Contingent considerations amounted to 16m have been paid during the interim period regarding Ropox, which was acquired in 2020.
Latest updated: 4/25/2023 2:14:42 PM by jamilah.wass@add.life